Search

Your search keyword '"Loos, Ruth"' showing total 3,188 results

Search Constraints

Start Over You searched for: Author "Loos, Ruth" Remove constraint Author: "Loos, Ruth"
3,188 results on '"Loos, Ruth"'

Search Results

202. Oligogenic Architecture of Rare Noncoding Variants Distinguishes 4 Congenital Heart Disease Phenotypes

203. Supplementary Figures S1-S11 from ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing

204. Data from ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing

205. Supplementary Tables S1-S19 from ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing

206. Abstract 3507: Mosaic chromosomal alterations in blood across ancestries via whole-genome sequencing

207. The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits

208. Returning integrated genomic risk and clinical recommendations: The eMERGE study

209. Supplementary Table 6 from Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk

210. Supplementary Tables 1 - 4 from Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk

211. Supplementary Table 5 from Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk

212. Data from Mammographic Breast Density and Breast Cancer: Evidence of a Shared Genetic Basis

213. Supplementary Figure 1 from Mammographic Breast Density and Breast Cancer: Evidence of a Shared Genetic Basis

214. Assessing efficiency of fine-mapping obesity associated variants through leveraging ancestry architecture and functional annotation using PAGE and UKBB Cohorts

215. Precision medicine in complex diseases-Molecular subgrouping for improved prediction and treatment stratification.

216. Genetic insights into resting heart rate and its role in cardiovascular disease

217. The genetic determinants of recurrent somatic mutations in 43,693 blood genomes.

218. GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification

219. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.

220. Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing.

221. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes

222. Distilling causality between physical activity traits and obesity via Mendelian randomization

223. Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing

224. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

225. Ancestral diversity in lipoprotein(a) studies helps address evidence gaps

226. Genetic insights into resting heart rate and its role in cardiovascular disease

227. Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts

228. Role of sociodemographic, clinical, behavioral, and molecular factors in precision prevention of type 2 diabetes:a systematic review

229. Genomic Disorders in CKD across the Lifespan

230. Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms

231. Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program

232. Approaches to addressing the rise in obesity levels

233. Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People with Type 2 Diabetes Mellitus

234. Rare variants in long non-coding RNAs are associated with blood lipid levels in the TOPMed whole-genome sequencing study.

235. Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development:a systematic review

236. A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies

237. Machine learning models for blood pressure phenotypes combining multiple polygenic risk scores

238. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

239. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

240. New insights in the mechanisms of weight-loss maintenance:Summary from a Pennington symposium

242. Discrepancy between predicted and measured exercise intensity for eliciting the maximal rate of lipid oxidation

243. PFAS Exposures and the Human Metabolome:A Systematic Review of Epidemiological Studies

244. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

245. Role of sociodemographic, clinical, behavioral, and molecular factors in precision prevention of type 2 diabetes: a systematic review

246. Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications

247. Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease

248. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention

250. Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference

Catalog

Books, media, physical & digital resources